Metaphore Biotechnologies Is A Biotechnology Company Based In Cambridgemassachusettsfounded In 2021 By Flagship Pioneeringthe Company Focuses On Developing Innovative Therapeutics Through Its Proprietary Mimic Platformwhich Integrates Machine Learning With Molecular Mimicrythis Approach Allows Metaphore To Engineer Therapeutics That Target Challenging Drug Targetsaiming To Improve Patient Outcomes Launched In May 2023Metaphore Secured $50 Million In Series A Funding From Flagship Pioneering To Advance Its Mimic Platform And Therapeutic Pipelinethe Company Specializes In Creating Novel Therapeutics By Optimizing Pharmacophoresenhancing Their Functionspecificityand Selectivitymetaphore Is Actively Working On A Diverse Pipeline Of Drug Candidates For Autoimmunemetabolicand Oncology Indicationsemploying Both Computational And Experimental Methods In Drug Discoverywith A Dedicated Team Of Around 30 Peoplemetaphore Is Recognized As A Leader In The Ai Derived Small Molecules Market
